NDA 214628 · Long Grove Pharms
Norepinephrine Bitartrate In 0.9% Sodium Chloride
Norepinephrine Bitartrate · Intravenous
Last checked: Nov 19, 2026Latest source record: Dec 3, 2024 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2022
Oct 6, 2022
Approved uses
1
Original approval plus efficacy supplements
Registered trials
13
2 Phase 3, 2 recruiting
FAERS reports
13,464
12,974 serious, 4,381 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Apr 30, 2026.
Norepinephrine in Sodium Chloride Injection is indicated to raise blood pressure in adult patients with severe, acute hypotension. Norepinephrine in Sodium Chloride Injection is a catecholamine indicated for restoration of blood pressure in adult patients with acute hypotensive states. ( 1 )
Mechanism: Norepinephrine is a peripheral vasoconstrictor (alpha-adrenergic action) and an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action).
Therapeutic areas: Kidney and urology
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
3 products under this application
- NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE · NOREPINEPHRINE BITARTRATE EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) · SOLUTION, INTRAVENOUS · Prescription
- NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE · NOREPINEPHRINE BITARTRATE EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) · SOLUTION, INTRAVENOUS · Prescription
- NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE · NOREPINEPHRINE BITARTRATE EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) · SOLUTION, INTRAVENOUS · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Norepinephrine Bitartrate" as an intervention, any sponsor and status, largest first.
- Norepinephrine Infusion Different Doses in Cesarean DeliveryPivotal-lookingCompleted
Cairo UniversityAcademic, hospital or other
NCT03182088 · 284 participants · Start Jun 15, 2017 · Primary completion Dec 25, 2017
Drug: norepinephrine infusion (0.025 mcg/Kg/min); norepinephrine infusion (0.050 mcg/Kg/min) and 2 more · For: Cesarean Section Complications
Sites: Cairo, Egypt
- Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal HypotensionPivotal-lookingCompleted
Mersin UniversityAcademic, hospital or other
NCT05502146 · 200 participants · Start Aug 17, 2022 · Primary completion Oct 1, 2022
Drug: Noradrenaline Bitartrate; Bupivacaine Hydrochloride and 2 more · For: Spinal Anesthetic Toxicity; Hypotension Drug-Induced; Cesarean Section Complications
Sites: Mersin, Turkey (Türkiye)
- Early Administration of Norepinephrine in SepsisPivotal-lookingRecruiting
Tunis UniversityAcademic, hospital or other
NCT05836272 · 200 participants (planned) · Start Aug 1, 2023 · Primary completion Jun 2025
Drug: Norepinephrine Bitartrate · For: Sepsis, Severe
Sites: Tunis, Tunisia
- Norepinephrine Versus Phenylephrine Continuous Variable Infusion in Cesarean DeliveryPivotal-lookingCompleted
Cairo UniversityAcademic, hospital or other
NCT03328533 · 123 participants · Start Nov 10, 2017 · Primary completion May 1, 2018
Drug: Phenylephrine; Norepinephrine and 1 more · For: Cesarean Section Complications; Spinal Anesthesia
Sites: Cairo, Egypt
- A Comparison of Intermittent Intravenous Boluses of Phenylephrine and Norepinephrine to Prevent Spinal-induced Hypotension in Cesarean DeliveriesPivotal-lookingCompleted
Samuel Lunenfeld Research Institute, Mount Sinai HospitalAcademic, hospital or other
NCT02962986 · 112 participants · Start Jan 2017 · Primary completion Apr 2017
Drug: Norepinephrine; Phenylephrine · For: Hypotension
Sites: Toronto, Canada
- Superiority of Phenylephrine Versus Norepinephrine in Complex Spine Surgery (SPiNeS)Not yet recruiting
Mayo ClinicAcademic, hospital or other
NCT07796282 · 50 participants (planned) · Start Sep 2026 · Primary completion May 2028
Drug: Phenylephrine hydrochloride infusion; Norepinephrine bitartrate infusion · For: Spine Surgery; Intraoperative Hypotension; Tissue Perfusion
Sites: Jacksonville, Florida
- Using Vasopressor Medication to Support Blood Pressure During Intubation ProcedurePivotal-lookingCompleted
Wright State UniversityAcademic, hospital or other
NCT05355974 · 42 participants · Start Aug 9, 2022 · Primary completion Jul 10, 2024
Drug: Norepinephrine; Lactated Ringers, Intravenous and 2 more · For: Respiratory Failure; Hypotension and Shock; Hypotension on Induction and 2 more
Sites: Dayton, Ohio
Samuel Lunenfeld Research Institute, Mount Sinai HospitalAcademic, hospital or other
NCT02654847 · 40 participants · Start Jan 2016 · Primary completion Mar 2016
Drug: Norepinephrine; Normal Saline · For: Hypotension
Sites: Toronto, Canada
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- drug ineffective2,961
- off label use1,391
- hypotension1,343
- acute kidney injury929
- multiple organ dysfunction syndrome891
- condition aggravated868
- sepsis740
- toxicity to various agents737
- cardiac arrest684
- cardiogenic shock683
- septic shock591
- respiratory failure514
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 64 |
| 2005 | 71 |
| 2006 | 90 |
| 2007 | 91 |
| 2008 | 79 |
| 2009 | 90 |
| 2010 | 120 |
| 2011 | 233 |
| 2012 | 161 |
| 2013 | 109 |
| 2014 | 187 |
| 2015 | 244 |
| 2016 | 358 |
| 2017 | 462 |
| 2018 | 491 |
| 2019 | 575 |
| 2020 | 1,384 |
| 2021 | 1,508 |
| 2022 | 1,422 |
| 2023 | 1,590 |
| 2024 | 1,549 |
| 2025 | 1,573 |
| 2026 | 1,012 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest.
Callaham M, Madsen CD, Barton CW, et al. · JAMA 1992 · Clinical Trial, Randomized Controlled Trial
Sponsor: Long Grove Pharms
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.